Yuva Bioscences
2 known investors
Yuva Biosciences uses an AI platform called MitoNova to discover compounds that improve mitochondrial health and address aging-related cellular decline. Its discovered compounds, such as Y100, are used in consumer products including Revive+ by BosleyMD for hair.
AI & Machine LearningBiotechLongevity
Investors · 2
Competitors · 5
by search overlapIdeaya Biosciences9 shared keywordsIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.
VedaBio7 shared keywordsVedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification. The platform serves research, diagnostics, and industrial applications across multiple markets.
Imvivabio7 shared keywordsImviva Bio develops allogeneic CAR-T cell therapies for cancer and autoimmune diseases, using its Imviva platform and ANSWER technology with immune-evasion science aimed at improving cell therapy performance and persistence.
Huya Bioscience International6 shared keywordsHUYABIO International develops novel biopharmaceutical products originating in China for global markets, working with biopharmaceutical, academic and commercial partners to advance drug candidates across all therapeutic areas. It maintains a large China-sourced compound portfolio and operates offices across the US, Japan, South Korea, Canada, Ireland and China.
Iovance6 shared keywordsIovance develops T-cell-based immunotherapies, including tumor-infiltrating lymphocyte (TIL) therapies and genetically modified TIL therapies, designed to target neoantigens unique to each patient's tumor. The company focuses on treating advanced solid tumor cancers and manufactures its therapies at its Cell Therapy Center in Philadelphia.
Companies competing with Yuva Bioscences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Yuva Bioscences do?
- Yuva Biosciences uses an AI platform called MitoNova to discover compounds that improve mitochondrial health and address aging-related cellular decline. Its discovered compounds, such as Y100, are used in consumer products including Revive+ by BosleyMD for hair.
- Who are Yuva Bioscences's investors?
- Yuva Bioscences's investors include TBD Angels, Western Technology Investment.